Overview

Evaluating Possible Improvement in Speech and Hearing Tests After 28 Days of Dosing of the Study Drug AUT00063 Compared to Placebo (QuicKfire)

Status:
Completed
Trial end date:
2017-04-01
Target enrollment:
Participant gender:
Summary
The objective of this pilot study is to explore whether repeat doses of AUT00063 can provide an indication of improvement in performance of tests across a battery of speech and hearing assessments in cochlear implant users.
Phase:
Phase 2
Details
Lead Sponsor:
Autifony Therapeutics Limited